TJ004309STM102 Biomarker of IHC
| Title | TJ004309STM102 Biomarker of IHC |
|---|---|
| Description | Uliledlimab (TJ004309,Anti-CD73 Antibody) and toripalimab combination therapy in treatment naive advanced NSCLC: Phase 1/2 clinical trial results using CD73 as a potential predictive biomarker. The data is a summary of the biomarker data in in treatment naive advanced NSCLC patients. |
| Organism | Homo sapiens |
| Data Type | Biomarker Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA016175 |
| Release Date | 2023-06-03 |
| Submitter | Mei Huang (mei.huang@i-mabbiopharma.com) |
| Organization | I-Mab Biopharma Co.,Ltd |
| Submission Date | 2023-04-11 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX003703-02 | TJ004309STM102 Biomarker of IHC-1 | 1 | Biomarker Data | 10.1 KB | xlsx | 0 | Controlled |